As of Oct 21
| +1.61 / +10.46%|
The 1 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 22.75, with a high estimate of 22.75 and a low estimate of 22.75. The median estimate represents a +33.82% increase from the last price of 17.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.